Phibro Animal Health Corporation (FRA:PB8)
Germany · Delayed Price · Currency is EUR 32.60
-0.20 (-0.61%)
At close: Jan 28, 2026
Phibro Animal Health Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 67.82 | 48.26 | 2.42 | 32.61 | 49.18 | 54.39 |
Depreciation & Amortization | 48.01 | 44.18 | 34.74 | 32.56 | 31.66 | 30.63 |
Other Amortization | 3.64 | 3.44 | 2.48 | 2.18 | 1.64 | 2.09 |
Asset Writedown & Restructuring Costs | 5.33 | 5.33 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -1.2 | - |
Stock-Based Compensation | 0.88 | 0.72 | 0.48 | - | - | 1.13 |
Other Operating Activities | 8.19 | -0.24 | 14.37 | -12.9 | -4.98 | -10.06 |
Change in Accounts Receivable | -53.05 | -55.21 | -8.68 | 5.34 | -23.63 | -18.21 |
Change in Inventory | -65.31 | -44.29 | 2.64 | -11.22 | -47 | -12.5 |
Change in Accounts Payable | 39.62 | 45.56 | 12 | -22.83 | 26.36 | 3.18 |
Change in Other Net Operating Assets | 21.68 | 32.39 | 27.15 | -12.42 | -0.37 | -2.34 |
Operating Cash Flow | 76.8 | 80.12 | 87.59 | 13.31 | 31.65 | 48.31 |
Operating Cash Flow Growth | -8.58% | -8.53% | 558.11% | -57.95% | -34.48% | -18.61% |
Capital Expenditures | -42.52 | -38.29 | -41.24 | -51.79 | -37.04 | -29.32 |
Cash Acquisitions | -286.53 | -286.53 | -3.28 | - | -13.51 | - |
Investment in Securities | 25.5 | 35 | -4 | -23 | 27.35 | 12 |
Other Investing Activities | -3.22 | 1.13 | 0.33 | 0.78 | 0.62 | -1.26 |
Investing Cash Flow | -306.77 | -288.69 | -48.19 | -74.02 | -22.58 | -18.58 |
Short-Term Debt Issued | - | 7.53 | 8.59 | 6.36 | - | - |
Long-Term Debt Issued | - | 1,182 | 276 | 326 | 297 | 617.5 |
Total Debt Issued | 708.53 | 1,190 | 284.59 | 332.36 | 297 | 617.5 |
Short-Term Debt Repaid | - | -6.56 | -8.62 | -1.14 | - | - |
Long-Term Debt Repaid | - | -946.01 | -263.3 | -283.32 | -256.38 | -612.13 |
Total Debt Repaid | -436.41 | -952.57 | -271.92 | -284.45 | -256.38 | -612.13 |
Net Debt Issued (Repaid) | 272.12 | 236.96 | 12.67 | 47.9 | 40.63 | 5.38 |
Common Dividends Paid | -19.45 | -19.45 | -19.44 | -19.44 | -19.44 | -19.43 |
Other Financing Activities | - | -10.38 | - | -1.47 | -4.84 | -2.94 |
Financing Cash Flow | 252.67 | 207.13 | -6.77 | 26.99 | 16.34 | -17 |
Foreign Exchange Rate Adjustments | -1.77 | -1.14 | -3.3 | 0.75 | -1.37 | 1.14 |
Net Cash Flow | 20.93 | -2.57 | 29.33 | -32.97 | 24.04 | 13.87 |
Free Cash Flow | 34.29 | 41.83 | 46.36 | -38.48 | -5.4 | 18.99 |
Free Cash Flow Growth | -15.70% | -9.76% | - | - | - | -24.96% |
Free Cash Flow Margin | 2.45% | 3.23% | 4.55% | -3.94% | -0.57% | 2.28% |
Free Cash Flow Per Share | 0.84 | 1.03 | 1.14 | -0.95 | -0.13 | 0.47 |
Cash Income Tax Paid | 13.4 | 13.4 | 15.43 | 20.41 | 17.85 | 19.4 |
Levered Free Cash Flow | -111.83 | -86.5 | 57.79 | -33.57 | 0.43 | 14.2 |
Unlevered Free Cash Flow | -88.42 | -66.47 | 71.13 | -22.62 | 7.77 | 21.3 |
Change in Working Capital | -57.06 | -21.56 | 33.11 | -41.13 | -44.64 | -29.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.